Artificial Intelligence for Drug-Likeness Prediction: An Intelligent Framework for Chemical Compound Screening
DOI:
https://doi.org/10.31305/rhimrj.2026.v13n09.002Keywords:
Artificial Intelligence, Drug-Likeness, Chemical Compounds, Drug Discovery, Molecular Descriptors, Chemical Screening, Explainable AI, Computational ChemistryAbstract
Drug discovery requires screening large numbers of chemical compounds to identify promising drug candidates. This study proposes an AI-based framework for predicting drug-likeness using molecular descriptors derived from chemical structures. The framework integrates data preprocessing, feature selection, machine learning model development, and performance evaluation using metrics such as accuracy, precision, recall, F1-score, and AUROC. An explainability component is also included to identify important molecular properties influencing predictions. The proposed approach can support early-stage compound screening by prioritizing potentially suitable drug candidates and reducing the need for costly experimental analysis.
References
[1] C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney, “Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings,” Advanced Drug Delivery Reviews, vol. 23, pp. 3–25, 1997. DOI: https://doi.org/10.1016/S0169-409X(96)00423-1
[2] Y. Zhu et al., “Current Trends and Challenges in Drug-Likeness Prediction: Are They Generalizable and Interpretable?” Health Data Science, vol. 3, 2023. DOI: https://doi.org/10.34133/hds.0098
[3] A. Gaulton et al., “ChEMBL: a large-scale bioactivity database for drug discovery,” Nucleic Acids Research. ChEMBL provides chemical structures, molecular properties and bioactivity information.
[4] B. Zdrazil et al., “The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods,” Nucleic Acids Research. DOI: https://doi.org/10.1093/nar/gkad1004
[5] W. Huang et al., “Drug-likeness scoring based on unsupervised learning,” Chemical Science, 2022.
[6] Recent work on chemical drug-likeness prediction using approved drugs and ZINC, ChEMBL and GDB17 datasets, Journal of Cheminformatics, 2024.
